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Objective	Angiotensin	Converting	Enzyme	(ACE)	is	expressed	in	human	skeletal	muscle.		The	ACE	I/D	polymorphism	 (rs4341)	 has	 been	 associated	 with	 athletic	 performance	 in	 some	 studies.	 Studies	suggested	 that	 the	ACE	 I/D	 gene	 polymorphism	 is	 associated	with	ACE	 enzyme	 content	 in	 serum,	however,	 the	 effect	 of	 ACE	 I/D	 on	 ACE	 protein	 content	 in	 human	 skeletal	 muscle	 in	 unclear.	Angiotensin-converting	enzyme	2	(ACE2)	is	a	new	component	of	the	renin-angiotensin	system	(RAS),	which	is	counter-regulatory	to	the	ACE	enzyme.	The	polymorphisms	in	the	ACE2	gene	(rs1978124	and	rs2285666)	have	been	reported	 to	be	associated	with	hypertension,	however,	 their	effects	on	ACE	content	in	the	blood	and	in	skeletal	muscle	have	yet	to	be	explored.	Utilising	the	Gene	SMART	cohort	(n=81),	 we	 investigated	 whether	 the	 ACE	 I/D	 gene	 polymorphism	 (rs4341)	 and	 two	 ACE2	 gene	polymorphisms	(rs1978124	and	rs2285666)	were	associated	with	ACE	enzyme	content	in	the	blood	and	 skeletal	muscle	 at	 baseline,	 and	 following	 a	 single	 session	 of	 High-Intensity	 Interval	 Exercise	(HIIE).	
Methods	ACE	and	ACE2	gene	polymorphisms	were	determined	using	the	TaqMan	SNP	assay	(Applied	Biosystems,	 Foster	 City,	 California,	 United	 States)	 by	 Mastercycler®	 ep	 realplex2	 (Eppendorf,	Hamburg,	Germany),	 and	QuantStudio™	7	Flex	Real-Time	PCR	System	(Applied	Biosystems,	Foster	City,	California,	United	States).	For	quantitation	of	ACE	content	in	the	plasma,	Abcam	Human	ELISA	Kit	(ab119577	–ACE	(CD143))	was	used	(Abcam,	Cambridge,	United	Kingdom).	Western	blots	were	used	to	measure	ACE	content	in	skeletal	muscle.	We	used	robust	linear	models	adjusted	for	age	to	test	the	effect	 of	 the	 ACE	 I/D	 polymorphism	 on	 outcomes	 at	 baseline,	 using	 the	 MASS	 package	 in	 the	 R	statistical	 software.	 p-values	 were	 adjusted	 for	 multiple	 comparisons	 using	 the	 Benjamini	 and	Hochberg	method,	and	all	reported	p-values	are	adjusted	p-values.	An	adjusted	p	value	<	0.005	was	considered	significant.	
Results	We	found	that	the	ACE	I/D	gene	polymorphism	was	associated	with	ACE	content	in	the	blood	(p<0.005)	 at	 baseline,	 but	 not	 the	 ACE	 protein	 content	 in	 skeletal	 muscle	 at	 baseline.	 The	 ACE2	polymorphisms	 (rs1978124	and	 rs2285666)	were	not	associated	with	ACE	enzyme	content	 in	 the	blood	or	in	skeletal	muscle	at	baseline.	A	single	session	of	HIIE	tended	(0.005	<	p	<	0.05)	to	increase	blood	ACE	content	immediately	post	exercise,	while	skeletal	muscle	ACE	protein	content	was	lower	3	hours	post		a	single	session	of	HIIE	(p<0.005).	However,	those	changes	were	not	related	to	ACE	I/D	or	
ACE2	polymorphisms.	
Conclusions	The	ACE	I/D	gene	polymorphism	influences	ACE	enzyme	content	in	the	blood	but	not	the	ACE	protein	content	of	human	skeletal	muscle.	ACE	 I/D	gene	polymorphism	does	not	 influence	the	changes	of	ACE	content	after	a	single	session	of	HIIE.	ACE2	gene	polymorphisms	seem	to	have	no	effect	on	ACE	content	in	the	blood	and	skeletal	muscle,	before	or	after	a	session	of	HIIE.		
